Lisdexamfetamine used to treat attention deficit hyperactivity disorder also improves executive functions commonly experienced in menopausal women.

"Reports of cognitive decline, particularly in executive functions, are widespread among menopausal women," said lead author C. Neill Epperson, professor of psychiatry, obstetrics and gynecology at the University of Pennsylvania.
The team administered a once-daily dose of LDX for four weeks to 32 healthy, non-ADHD-diagnosed women experiencing difficulties due to onset of menopause. They were randomly assigned to cross-over to a placebo for an additional four weeks.
The team found a 41 percent overall improvement in executive functions for women receiving LDX, compared to a 17 percent improvement when taking placebo medication.
"Although we observed that short-term use of LDX was well-tolerated and effective in several subjective and objective areas, long-term studies of menopausal women receiving LDX are needed, similar to those conducted for ADHD patients," Epperson added.
Source-IANS
MEDINDIA




Email










